Iopamiro (Iopamidol)

• Iopamiro (iopamidol) is an iodinated contrast agent used to enhance X‑ray imaging of vascular and tissue structures.
• Angiography: provides high‑contrast visualization of blood vessels during catheter‑based imaging procedures.
• CT imaging: improves delineation of organs and lesions for accurate computed tomography scans.
• Myelography: creates clear contrast between cerebrospinal fluid and surrounding structures for spinal imaging.
• Interventional radiology procedures: enhances anatomical detail during minimally invasive therapeutic interventions.

• Iopamidol contains a high density of iodine atoms that absorb X‑ray photons, increasing attenuation of the X‑ray beam. After intravenous, intra‑arterial, or intrathecal administration, the agent distributes rapidly within the extracellular fluid, outlining vascular and tissue compartments. The resulting difference in X‑ray absorption creates contrast between the enhanced structures and adjacent tissues, allowing detailed radiographic visualization without interacting with specific cellular receptors.

Iopamiro may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Warmth or flushing sensation at the injection site
• Nausea or vomiting
• Mild headache
• Metallic taste in the mouth
• Urticaria or mild skin rash
• Injection‑site pain or discomfort

Serious or Rare Side Effects

• Anaphylactic or severe allergic reaction
• Acute renal impairment or contrast‑induced nephropathy
• Seizures or convulsions
• Hypotension or cardiovascular collapse
• Cardiac arrhythmias
• Pulmonary edema or respiratory distress

• Before administering Iopamiro, clinicians should consider several safety measures.
• Renal function assessment: evaluate baseline kidney function to identify patients at risk of nephrotoxicity.
• Allergy history: screen for prior reactions to iodine‑based contrast media.
• Hydration: ensure adequate patient hydration to reduce renal injury risk.
• Thyroid function: monitor patients with hyperthyroidism or thyroid disorders.
• Pregnancy and lactation: use only when clearly necessary, weighing potential fetal or infant risk.
• Store at controlled room temperature (below 25°C): keep in the original container, protect from light and moisture.

Iopamiro can interact with other medicines, requiring attention to avoid or monitor effects.

Major Interactions (Avoid)

• Iodinated contrast agents + high‑dose iodine thyroid medication: may precipitate thyroid dysfunction.
• Iopamidol + nephrotoxic drugs (e.g., aminoglycosides, NSAIDs): increased risk of renal injury.
• Iopamidol + metformin: potential for lactic acidosis in patients